![](/img/cover-not-exists.png)
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study
W. E. Schmidt, J. S. Christiansen, M. Hammer, M. J. Zychma, J. B. BuseVolume:
28
Year:
2011
Language:
english
DOI:
10.1111/j.1464-5491.2011.03276.x
File:
PDF, 234 KB
english, 2011